메뉴 건너뛰기
.. 내서재 .. 알림
소속 기관/학교 인증
인증하면 논문, 학술자료 등을  무료로 열람할 수 있어요.
한국대학교, 누리자동차, 시립도서관 등 나의 기관을 확인해보세요
(국내 대학 90% 이상 구독 중)
로그인 회원가입 고객센터 ENG
주제분류

추천
검색

이용수

표지
📌
연구주제
📖
연구배경
🔬
연구방법
🏆
연구결과
AI에게 요청하기
추천
검색

초록· 키워드

오류제보하기
Duchenne muscular dystrophy (DMD) is characterized by a predictable decline in skeletal muscle strength leading to loss of ambulation, respiratory failure, and death in the second and third decade of life. No cure is yet available, but nowadays the oral corticosteroid has become a standard care, although there is a lack of consensus on the optimal treatment regimen. However, oral corticosteroid therapy has not yet popularly offered to DMD patients due to its possible negative effects in our country. Therefore, we want to report our case of DMD with long term periodic deflazacort therapy, which led to improvement in muscle strength without any serious side effects to stop the medication. After the therapy, he showed improvement in functional status from wheelchair-bounded to independent ambulator with walking aid, and didn’t show aggravation in scoliosis and respiratory function. Osteoporosis was developed after one year of treatment, but it was effectively managed with medications.

목차

등록된 정보가 없습니다.

참고문헌 (10)

참고문헌 신청

함께 읽어보면 좋을 논문

논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!

이 논문의 저자 정보

최근 본 자료

전체보기

댓글(0)

0